Evidence map›Paper›PMID 36816631›Full record

ArticleACS omega2023

Nanocomposite of CO

Mohammad Alroaithi, Wei Xu

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mohammad AlroaithiFuel & Chemicals, Aramco Research Center, King Abdullah University of Science and Technology, Thuwal23955-8433, Kingdom of Saudi Arabia.ORCID https://orcid.org/0000-0003-1488-8189
Wei XuFuel & Chemicals, Aramco Research Center, King Abdullah University of Science and Technology, Thuwal23955-8433, Kingdom of Saudi Arabia.
Saudi Aramco (Saudi Arabia) · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polypropylene carbonate (PPC) derived from carbon dioxide has been used as a precursor for the synthesis of polyurethane (PU). The high viscosity of the PPC is the key parameter hindering its processability during PU synthesis. Herein, a PPC nanocomposite with highly exfoliated nanoclay was prepared through a solution intercalation process. A wide range of nanoclay concentrations incorporated into the PPC were studied. The impacts of the nanoclay on the PPC were investigated in order to maintain the polymer structure while improving its physical properties. The characterizations of PPC nanocomposites showed that the highly exfoliated nanoclay contributed to a viscosity reduction, and a slight reduction in the molecular weight. The polymer degradation was indicated by the formation of cyclic propylene carbonate. The minimum or critical concentration of nanoclay was found to be between ∼0.5 and 2.0 wt %. Within this range, the polymer degradation is minimal. The PPC nanocomposites with a lower viscosity showed excellent precursors for making PU coating materials. The PU coating derived from the PPC nanocomposite has higher anticorrosive properties in comparison with the non-modified PU coating.

Identifiers

PMID36816631
PMCPMC9933217
OpenAlexW4318776553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.